ロード中...
Preclinical and clinical implications of TERT promoter mutation in glioblastoma multiforme
The promoter region of the telomerase reverse transcriptase gene (TERT) is mutated in a subpopulation of patients with glioblastoma multiforme (GBM). In the present study, preclinical and clinical implications of the mutation were analyzed in 25 GBMs to evaluate its utility as a therapeutic target....
保存先:
| 出版年: | Oncol Lett |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5755188/ https://ncbi.nlm.nih.gov/pubmed/29344264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7196 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|